Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.
Reis H, Pütter C, Megger DA, Bracht T, Weber F, Hoffmann AC, Bertram S, Wohlschläger J, Hagemann S, Eisenacher M, Scherag A, Schlaak JF, Canbay A, Meyer HE, Sitek B, Baba HA. Reis H, et al. Among authors: megger da. Biochim Biophys Acta. 2015 Jun;1854(6):641-50. doi: 10.1016/j.bbapap.2014.10.024. Epub 2014 Nov 5. Biochim Biophys Acta. 2015. PMID: 25448011
Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation.
Naboulsi W, Bracht T, Megger DA, Reis H, Ahrens M, Turewicz M, Eisenacher M, Tautges S, Canbay AE, Meyer HE, Weber F, Baba HA, Sitek B. Naboulsi W, et al. Among authors: megger da. Biochim Biophys Acta. 2016 Nov;1864(11):1579-85. doi: 10.1016/j.bbapap.2016.08.005. Epub 2016 Aug 9. Biochim Biophys Acta. 2016. PMID: 27519163
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
Megger DA, Bracht T, Kohl M, Ahrens M, Naboulsi W, Weber F, Hoffmann AC, Stephan C, Kuhlmann K, Eisenacher M, Schlaak JF, Baba HA, Meyer HE, Sitek B. Megger DA, et al. Mol Cell Proteomics. 2013 Jul;12(7):2006-20. doi: 10.1074/mcp.M113.028027. Epub 2013 Mar 5. Mol Cell Proteomics. 2013. PMID: 23462207 Free PMC article.
A practical data processing workflow for multi-OMICS projects.
Kohl M, Megger DA, Trippler M, Meckel H, Ahrens M, Bracht T, Weber F, Hoffmann AC, Baba HA, Sitek B, Schlaak JF, Meyer HE, Stephan C, Eisenacher M. Kohl M, et al. Among authors: megger da. Biochim Biophys Acta. 2014 Jan;1844(1 Pt A):52-62. doi: 10.1016/j.bbapap.2013.02.029. Epub 2013 Mar 15. Biochim Biophys Acta. 2014. PMID: 23501674 Free article.
Label-free quantification in clinical proteomics.
Megger DA, Bracht T, Meyer HE, Sitek B. Megger DA, et al. Biochim Biophys Acta. 2013 Aug;1834(8):1581-90. doi: 10.1016/j.bbapap.2013.04.001. Epub 2013 Apr 6. Biochim Biophys Acta. 2013. PMID: 23567906 Review.
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.
Padden J, Megger DA, Bracht T, Reis H, Ahrens M, Kohl M, Eisenacher M, Schlaak JF, Canbay AE, Weber F, Hoffmann AC, Kuhlmann K, Meyer HE, Baba HA, Sitek B. Padden J, et al. Among authors: megger da. Mol Cell Proteomics. 2014 Oct;13(10):2661-72. doi: 10.1074/mcp.M113.034942. Epub 2014 Jul 17. Mol Cell Proteomics. 2014. PMID: 25034945 Free PMC article.
Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
Padden J, Ahrens M, Kälsch J, Bertram S, Megger DA, Bracht T, Eisenacher M, Kocabayoglu P, Meyer HE, Sipos B, Baba HA, Sitek B. Padden J, et al. Among authors: megger da. Mol Cell Proteomics. 2016 Mar;15(3):1072-82. doi: 10.1074/mcp.M115.054585. Epub 2015 Dec 7. Mol Cell Proteomics. 2016. PMID: 26644413 Free PMC article.
45 results